Free Trial

Janus Henderson Group PLC Sells 86,712 Shares of Centene Co. (NYSE:CNC)

Centene logo with Medical background

Janus Henderson Group PLC lowered its holdings in shares of Centene Co. (NYSE:CNC - Free Report) by 9.9% in the 4th quarter, according to its most recent 13F filing with the Securities & Exchange Commission. The fund owned 785,360 shares of the company's stock after selling 86,712 shares during the quarter. Janus Henderson Group PLC owned approximately 0.16% of Centene worth $47,577,000 as of its most recent filing with the Securities & Exchange Commission.

Other institutional investors have also recently made changes to their positions in the company. Stratos Wealth Partners LTD. raised its position in Centene by 4.1% in the fourth quarter. Stratos Wealth Partners LTD. now owns 4,094 shares of the company's stock worth $248,000 after acquiring an additional 163 shares during the period. Capital Advisors Ltd. LLC increased its stake in shares of Centene by 75.3% in the 4th quarter. Capital Advisors Ltd. LLC now owns 412 shares of the company's stock worth $25,000 after purchasing an additional 177 shares in the last quarter. Private Trust Co. NA raised its holdings in Centene by 23.7% in the 4th quarter. Private Trust Co. NA now owns 956 shares of the company's stock worth $58,000 after purchasing an additional 183 shares during the period. Howard Capital Management Inc. grew its holdings in Centene by 5.4% during the fourth quarter. Howard Capital Management Inc. now owns 3,591 shares of the company's stock valued at $218,000 after purchasing an additional 184 shares during the period. Finally, Intellectus Partners LLC increased its position in Centene by 2.8% in the fourth quarter. Intellectus Partners LLC now owns 7,224 shares of the company's stock worth $438,000 after buying an additional 200 shares in the last quarter. Institutional investors own 93.63% of the company's stock.

Centene Price Performance

Shares of Centene stock opened at $59.02 on Wednesday. The firm has a market cap of $29.37 billion, a PE ratio of 9.46, a PEG ratio of 0.80 and a beta of 0.48. The stock has a 50 day moving average of $60.59 and a 200 day moving average of $60.47. The company has a current ratio of 1.11, a quick ratio of 1.10 and a debt-to-equity ratio of 0.70. Centene Co. has a 12 month low of $55.03 and a 12 month high of $80.59.

Centene (NYSE:CNC - Get Free Report) last posted its earnings results on Friday, April 25th. The company reported $2.90 EPS for the quarter, beating analysts' consensus estimates of $2.52 by $0.38. The firm had revenue of $46.62 billion during the quarter, compared to the consensus estimate of $43.16 billion. Centene had a return on equity of 13.85% and a net margin of 2.03%. The company's quarterly revenue was up 15.4% compared to the same quarter last year. During the same period in the prior year, the company earned $2.26 EPS. On average, research analysts expect that Centene Co. will post 6.86 EPS for the current fiscal year.

Analyst Upgrades and Downgrades

A number of research analysts recently issued reports on CNC shares. Wells Fargo & Company cut their price objective on Centene from $76.00 to $72.00 and set an "overweight" rating for the company in a research note on Friday, February 14th. Barclays dropped their price target on shares of Centene from $93.00 to $84.00 and set an "overweight" rating for the company in a research report on Monday, April 28th. Robert W. Baird decreased their price objective on shares of Centene from $71.00 to $69.00 and set a "neutral" rating on the stock in a research report on Tuesday, April 15th. Jefferies Financial Group dropped their target price on shares of Centene from $64.00 to $61.00 and set a "hold" rating for the company in a report on Tuesday, April 29th. Finally, Argus cut Centene from a "buy" rating to a "hold" rating in a report on Thursday, February 6th. Seven research analysts have rated the stock with a hold rating and ten have assigned a buy rating to the company's stock. According to MarketBeat, the stock presently has an average rating of "Moderate Buy" and an average price target of $79.77.

Check Out Our Latest Research Report on Centene

Centene Profile

(Free Report)

Centene Corporation operates as a healthcare enterprise that provides programs and services to under-insured and uninsured families, commercial organizations, and military families in the United States. The company operates through Medicaid, Medicare, Commercial, and Other segments. The Medicaid segment offers health plan coverage, including medicaid expansion, aged, blind, disabled, children's health insurance program, foster care, medicare-medicaid plans, long-term services and support.

Featured Stories

Want to see what other hedge funds are holding CNC? Visit HoldingsChannel.com to get the latest 13F filings and insider trades for Centene Co. (NYSE:CNC - Free Report).

Institutional Ownership by Quarter for Centene (NYSE:CNC)

This instant news alert was generated by narrative science technology and financial data from MarketBeat in order to provide readers with the fastest and most accurate reporting. This story was reviewed by MarketBeat's editorial team prior to publication. Please send any questions or comments about this story to contact@marketbeat.com.

Should You Invest $1,000 in Centene Right Now?

Before you consider Centene, you'll want to hear this.

MarketBeat keeps track of Wall Street's top-rated and best performing research analysts and the stocks they recommend to their clients on a daily basis. MarketBeat has identified the five stocks that top analysts are quietly whispering to their clients to buy now before the broader market catches on... and Centene wasn't on the list.

While Centene currently has a Moderate Buy rating among analysts, top-rated analysts believe these five stocks are better buys.

View The Five Stocks Here

7 Stocks That Could Be Bigger Than Tesla, Nvidia, and Google Cover

Looking for the next FAANG stock before everyone has heard about it? Enter your email address to see which stocks MarketBeat analysts think might become the next trillion dollar tech company.

Get This Free Report
Like this article? Share it with a colleague.

Featured Articles and Offers

Recent Videos

7 Nuclear Stocks One Announcement Away from Exploding
3 AI ETFs for Steady Gains in 2025 (Without the Wild Volatility)
Goldman Sachs Warns of 20% Market Drop—Are They Right?

Stock Lists

All Stock Lists

Investing Tools

Calendars and Tools

Search Headlines